Background and Objectives: There is increase in lipid peroxidation with consequent increase in hemolysis when blood is stored in di–(2–ethyl hexyl)phthalate (DEHP) plasticized bags. Studies carried out by us and others have indicated the ability of red cells to synthesize NAD+ from added nicotinic acid. Apart from the role of NAD+ in glycolysis, NADPH is required for reduction of oxidized glutathione to its reduced form by glutathione reductase. Reduced glutathione is an important antioxidant, which protects cell membrane from oxidative damage. Reduced glutathione is also involved in the regeneration of vitamin E, another important membrane antioxidant. In view of these, a study was undertaken to find out the effect of addition of nicotinic acid to the citrate–phosphate–dextrose–adenine (CPDA) solution on lipid peroxidation and integrity of red cells when whole blood is stored in DEHP plasticized bags. Materials and Methods: Blood was collected in Penpol blood storage bags (which is a DEHP plasticized bag) in CPDA solution in the presence and absence of nicotinic acid. Various parameters of lipid peroxidation and membrane stability – level of malondialdehyde (MDA), conjugated dienes, vitamin E, reduced glutathione, plasma Hb and K+, levels of adenosine triphosphate (ATP) and 2,3–diphosphoglycerate (2,3–DPG) were studied in the blood samples after various periods. Results: Plasma Hb and K+ concentrations were significantly lower in the presence of added nicotinic acid both after 28 and 42 days. Concentration of MDA and conjugated dienes was lower and the levels of reduced glutathione and vitamin E higher in the presence of nicotinic acid. ATP levels were not significantly different, but 2,3–DPG levels were higher. pH of the blood was nearer to 7.0 in the presence of nicotinic acid, while leaching out of DEHP into the blood was significantly lower. Conclusion: Inclusion of nicotinic acid in the CPDA solution has a beneficial effect in that (1) it reduces plasma Hb and K+; (2) reduces lipid peroxidation and increases antioxidant protection; (3) maintains pH nearer to 7.0, and (4) decreases the leaching out of DEHP into the blood.

1.
Deepadevi KV, Manojkumar V, Arun P, Anitha Santhosh, Padmakumaran Nair KG, Lakshmi LR, Kurup PA: Increased lipid peroxidation of erythrocytes in blood stored in polyvinyl chloride blood storage bags plasticized with di–(2–ethyl hexyl)phthalate and effect of antioxidants. Vox Sang 1998;75:198–204.
2.
Racek J, Herynkova R, Holecek V, Jerabek Z, Slama V: Influence of antioxidants on the qualitiy of stored blood. Vox Sang 1997;72: 16–19.
3.
Myllyla G: Whole blood and plasma procurement and the impact of plasmapheresis; in Harris JR (ed): Blood Separation and Plasma Fractionation. New York, Wiley–Liss, 1991, pp 24–25.
4.
Anitha Santosh, Lakshmi LR, Arun P, Deepadevi KV, Padmakumaran Nair KG, Manojkumar V, Kurup PA: Synthesis of NAD+ in erythrocytes incubated with nicotinic acid and the effect of di–(2–ethyl hexyl)phthalate (DEHP). Indian J Biochem Biophys, 1998;35: 236–240.
5.
Feola M, Simoni J, Tran R, Canizaro PC: Mechanism of toxicity of hemoglobin solution; in Chang TMS, Geyer RP (eds): Blood Substitute, ed 1. New York, Marcel Dekker, 1989, pp 217–226.
6.
Mollison PL: in Blood Transfusion in Clinical Medicine, ed 6. Oxford, Blackwell, 1980, pp 638–639.
7.
Hoff HE, Smith PK, Winkler AW: The cause of death in experimental anuria. J Clin Invest 1941;20:607.
8.
Campbell WAB: Potassium levels in exchange transfusion. Arch Dis Childh 1955;30:513.
9.
Jacob RA: Nutrition, health and antioxidants. INFORM 1994;5:1271–1275.
10.
Tulpule PG: A comparative study of the synthesis of nicotinamide nucleotides by erythrocytes of some vertebrates. Biochem J 1963;87: 301–305.
11.
Micheli V, Simmonds HA, Sestini S, Ricci C: Importance of nicotinamide as an NAD+ precursor in the human erythrocyte. Arch Biochem Biophys 1990;283:40–45.
12.
Wills ED: Lipid peroxide formation in microsomes – general consideration. Biochem J 1969;113:315–324.
13.
Brien PJO: Estimation of conjugated dienes and hydroperoxides. Can J Biochem 1969;47: 485–489.
14.
Beutler E, Duran O, Kelley BM: Modified procedure for the estimation of reduced glutathione. J Lab Clin Med 1963;61:882–885.
15.
Colin G Rammel, Cunlifee B, Keiboom AJ: Determination of α–tocopherol in biological specimens by high performance liquid chromatography. J Liquid Chromatogr 1983;6: 1123–1130.
16.
Rock G, Secours VE, Franklin CA, Chu I, Villeneuve DC: Accumulation of mono–(2–ethyl hexyl)phthalate during storage of whole blood and plasma. Transfusion 1978;18:553–558.
17.
Bennet CA, Franklin NL: Statistical Analysis in Chemistry. New York, Wiley, 1976, pp 105–108.
18.
Greenwatt TJ, Bryan DJ, Dumaswala UJ: Erythrocyte membrane vesiculation and changes in membrane composition during storage in citrate–phosphate–dextrose–adenine–1. Vox Sang 1984;47:261–270.
19.
Hogman CF: Liquid storage of human erythrocytes; in Harris JR (ed): Blood Separation and Plasma Fractionation. New York, Wiley–Liss, 1991, pp 63–97.
20.
AuBuchon JP, Estep TN, Davey RJ: The effect of the plasticizer di–(2–ethyl hexyl)phthalate on the survival of stored RBCs. Blood 1988; 71:448–452.
21.
Thomas JA, Thomas MJ: Biological effects of di–(2–ethyl hexyl)phthalate and other phthalic acid esters. CRC Crit Rev Toxicol 1984;13: 283–317.
22.
Seth PK: Hepatic effects of phthalate esters. Environ Health Perspect 1982;45:27–34.
23.
Reddy JK, Lalwai ND: Carcinogenesis by hepatic peroxisome proliferators, evaluation of risk of hypolipidemic drugs and industrial plasticizers to humans. CRC Crit Rev Toxicol 1984;12:1–58.
24.
Padmakumaran Nair KG: Deepadevi KV, Arun P, Manojkumar V, Anitha Santhosh, Lakshmi LR, Kurup PA: Toxic effects of systemic administration of low doses of the plasticizer di–(2–ethyl hexyl)phthalate (DEHP) in rats. Indian J Exp Biol 1998;36:264–272.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.